In contrast, the expression of HLA-DR on CD14+ CD16− monocytes, HLA-DR on CD14+ CD16+ monocytes, and the percentage of Naive CD4+ T cells are associated with an increased risk of BC. This evidence concerns the gene CD4 and breast cancer.